Hikma Pharmaceutical reported $40M in Ordinary Share Capital for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Artemis Alpha ATS:LN GBP 373K 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
Galapagos GLPG:NA EUR 293.6M 1000
Genmab GEN:DC DKK 66M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Hikma Pharmaceutical HIK:LN USD 40M 1000K
Merck MRK:GR EUR 168M 397M
Orion ORNBV:FH EUR 92.2M 0
Recordati REC:IM EUR 26.14M 0
Roche Holding ROG:VX 107M 0